What is ArriVent BioPharma, Inc.'s EBITDA?

ArriVent BioPharma, Inc. (AVBP) reported EBITDA of -$46.67M in Q1 2026.

How has ArriVent BioPharma, Inc.'s EBITDA changed year-over-year?

ArriVent BioPharma, Inc.'s EBITDA increased by 30.9% year-over-year, from -$67.53M to -$46.67M.

What does EBITDA mean?

Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.

ArriVent BioPharma, Inc. AVBP EBITDA

EBITDA at other companies

Syndax PharmaceuticalsSNDX

-$30.2M+63.9%

ImmunomeIMNM

-$58.73M-33.4%

Arcus BiosciencesRCUS

-$132M-10.9%

Erasca, Inc.ERAS

-$187.19M-438%

Bicara TherapeuticsBCAX

-$60.2M-44.1%

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Operating income-$46.1M+30.9%

Net income-$43.3M+32.7%

EPS (diluted)-$0.96+49.5%

Balance sheet

See full

Cash & equivalents$62.1M+24.5%

Total debt$419.0K+204%

Total equity$324.0M+60.0%

Total assets$349.3M+62.1%

Cash flow

See full

Operating cash flow-$41.9M+38.4%

Valuation

See full

Market cap$1.49B+62.1%

Returns & leverage

See full

Return on equity-55.2%+8.0pp

Debt / equity0×0.0×

Current ratio14×-0.4×

Where this comes from

Calculated from ArriVent BioPharma, Inc.’s reported figures.

−$46.1Mebit−

$559.0KDepreciation Depletion & Amortization

=-$46.67M

The official record: ArriVent BioPharma, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about ArriVent BioPharma, Inc.'s ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ArriVent BioPharma, Inc.'s EBITDA?: ArriVent BioPharma, Inc. (AVBP) reported EBITDA of -$46.67M in Q1 2026.
How has ArriVent BioPharma, Inc.'s EBITDA changed year-over-year?: ArriVent BioPharma, Inc.'s EBITDA increased by 30.9% year-over-year, from -$67.53M to -$46.67M.
What does EBITDA mean?: Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.